This study is an international registry exploring how an Artificial Intelligence (AI) tool can help match cancer patients to clinical trials. The AI tool, called SYNERGY-AI, uses your existing electronic health records to find suitable trials. It's being tested to see how well it helps patients with various cancers, including pancreatic, liver, and stomach cancer, find and enroll in trials. The study is also looking at the financial impact and potential benefits of using this AI tool. To join, you need to have solid or blood cancers and specific cancer-related biomarkers (like PD-L1, MSI, HER2/Neu, TMB, ABL1, BRAF, BRCA1, BRCA2, EGFR, KRAS, and many others). The study is currently enrolling patients, with a goal of 50,000 participants.

Study design

This is an observational study, meaning it watches what happens without giving specific treatments. It aims to enroll 50,000 patients.

What's involved

You would voluntarily enroll in the registry. There are no extra tests or procedures required by the study; all treatment decisions are made by your doctor.

Compensation

Not stated in the trial record.

Follow-up

Your eligibility for clinical trials will be measured for about one year. Data collection will occur every 3 months for about 12 months after the last patient enrolls.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.